Loading chat...
NY A09580
Bill
Status
3/16/2022
Primary Sponsor
Linda Rosenthal
Click for details
AI Summary
-
Prohibits prior authorization, step therapy, and other restrictive protocols for antiretroviral prescription drugs in state public health plans used to treat or prevent HIV/AIDS.
-
Requires managed care providers to dispense antiretroviral drugs without prior authorization, step therapy, or other protocols that could delay or restrict distribution for HIV/AIDS treatment or prevention.
-
Prohibits individual and group health insurance policies from subjecting antiretroviral drugs to prior authorization, step therapy, or other restrictive protocols for HIV/AIDS treatment or prevention.
-
Applies the same restrictions to contracts issued by medical expense indemnity corporations, hospital service corporations, and health services corporations that cover antiretroviral drugs.
-
Becomes effective January 1 following enactment, with insurance policy provisions applying to all coverage issued or renewed on or after the effective date.
Legislative Description
Prohibits the preferred drug program, managed care programs and insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).
Last Action
referred to insurance
3/16/2022